Ede-Golightly James 4
4 · Silence Therapeutics plc · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Ede-Golightly James
Director
Transactions
- Award
Share Option (Right to Buy)
2026-01-02+90,000→ 90,000 totalExercise: $2.05Exp: 2036-01-02→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]This option shall vest in equal monthly installments over a one-year period measured from one month following January 2, 2026, subject to the Reporting Person's continuous service as of each applicable vesting date.